The Native State of Prion Protein (PrP) Directly Inhibits Formation of PrP-amyloid Fibrils in Vitro

Overview

Journal Sci Rep

Specialty Science

Date 2017 Apr 5

PMID 28373719

Citations 3

Authors

Ryo P Honda

Kazuo Kuwata

Affiliations

Soon will be listed here.

Abstract

The conversion of globular proteins into amyloid fibrils is associated with a wide variety of human diseases. One example is the prion protein (PrP), which adopts an α-helical structure in the native state but its amyloid form is implicated in the pathogenesis of prion diseases. Previous evidence has suggested that destabilization of the native state promotes amyloid formation, but the underlying mechanism remains unknown. In this study, we report that the native state of PrP serves as a potent inhibitor in the formation of PrP amyloid fibrils. By monitoring the time courses of thioflavin T fluorescence, the kinetics of amyloid formation was studied in vitro under various concentrations of pre-formed amyloid, monomer, and denaturant. Quantitative analysis of the kinetic data using various models of enzyme kinetics suggested that the native state of PrP is either an uncompetitive or noncompetitive inhibitor of amyloid formation. This study highlights the significant role of the native state in inhibiting amyloid formation, which provides new insights into the pathogenesis of misfolding diseases.

Citing Articles

Competing addition processes give distinct growth regimes in the assembly of 1D filaments.

Akram S, Brown T, Whitelam S, Meisl G, Knowles T, Schmit J Biophys J. 2025; 124(5):778-788.

PMID: 39876561 PMC: 11897546. DOI: 10.1016/j.bpj.2025.01.018.

Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates.

Sangar D, Hill E, Jack K, Batchelor M, Mistry B, Ribes J Elife. 2024; 13.

PMID: 39109999 PMC: 11377041. DOI: 10.7554/eLife.83320.

Direct Observation of Competing Prion Protein Fibril Populations with Distinct Structures and Kinetics.

Sun Y, Jack K, Ercolani T, Sangar D, Hosszu L, Collinge J ACS Nano. 2023; 17(7):6575-6588.

PMID: 36802500 PMC: 10100569. DOI: 10.1021/acsnano.2c12009.

Role of the Disulfide Bond in Prion Protein Amyloid Formation: A Thermodynamic and Kinetic Analysis.

Honda R Biophys J. 2018; 114(4):885-892.

PMID: 29490248 PMC: 5984966. DOI: 10.1016/j.bpj.2017.12.031.

References

Hosszu L, Baxter N, Jackson G, Power A, Clarke A, Waltho J . Structural mobility of the human prion protein probed by backbone hydrogen exchange. Nat Struct Biol. 1999; 6(8):740-3. DOI: 10.1038/11507. View

Yanagi K, Sakurai K, Yoshimura Y, Konuma T, Lee Y, Sugase K . The monomer-seed interaction mechanism in the formation of the β2-microglobulin amyloid fibril clarified by solution NMR techniques. J Mol Biol. 2012; 422(3):390-402. DOI: 10.1016/j.jmb.2012.05.034. View

Cannon M, Williams A, Wetzel R, Myszka D . Kinetic analysis of beta-amyloid fibril elongation. Anal Biochem. 2004; 328(1):67-75. DOI: 10.1016/j.ab.2004.01.014. View

Buell A, Galvagnion C, Gaspar R, Sparr E, Vendruscolo M, Knowles T . Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation. Proc Natl Acad Sci U S A. 2014; 111(21):7671-6. PMC: 4040554. DOI: 10.1073/pnas.1315346111. View

Moulick R, Udgaonkar J . Identification and Structural Characterization of the Precursor Conformation of the Prion Protein which Directly Initiates Misfolding and Oligomerization. J Mol Biol. 2017; 429(6):886-899. DOI: 10.1016/j.jmb.2017.01.019. View

Jain S, Udgaonkar J . Evidence for stepwise formation of amyloid fibrils by the mouse prion protein. J Mol Biol. 2008; 382(5):1228-41. DOI: 10.1016/j.jmb.2008.07.052. View

Fandrich M, Forge V, Buder K, Kittler M, Dobson C, Diekmann S . Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc Natl Acad Sci U S A. 2003; 100(26):15463-8. PMC: 307590. DOI: 10.1073/pnas.0303758100. View

Cohen S, Linse S, Luheshi L, Hellstrand E, White D, Rajah L . Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A. 2013; 110(24):9758-63. PMC: 3683769. DOI: 10.1073/pnas.1218402110. View

Scheibel T, Bloom J, Lindquist S . The elongation of yeast prion fibers involves separable steps of association and conversion. Proc Natl Acad Sci U S A. 2004; 101(8):2287-92. PMC: 356943. DOI: 10.1073/pnas.0308754101. View

10.

Buell A, Blundell J, Dobson C, Welland M, Terentjev E, Knowles T . Frequency factors in a landscape model of filamentous protein aggregation. Phys Rev Lett. 2010; 104(22):228101. DOI: 10.1103/PhysRevLett.104.228101. View

11.

Yau J, Sharpe S . Structures of amyloid fibrils formed by the prion protein derived peptides PrP(244-249) and PrP(245-250). J Struct Biol. 2012; 180(2):290-302. DOI: 10.1016/j.jsb.2012.08.002. View

12.

Milto K, Michailova K, Smirnovas V . Elongation of mouse prion protein amyloid-like fibrils: effect of temperature and denaturant concentration. PLoS One. 2014; 9(4):e94469. PMC: 3991587. DOI: 10.1371/journal.pone.0094469. View

13.

Kawahara K, Tanford C . Viscosity and density of aqueous solutions of urea and guanidine hydrochloride. J Biol Chem. 1966; 241(13):3228-32. View

14.

Legname G, Baskakov I, Nguyen H, Riesner D, Cohen F, DeArmond S . Synthetic mammalian prions. Science. 2004; 305(5684):673-6. DOI: 10.1126/science.1100195. View

15.

Caughey B . Interactions between prion protein isoforms: the kiss of death?. Trends Biochem Sci. 2001; 26(4):235-42. DOI: 10.1016/s0968-0004(01)01792-3. View

16.

Kuwata K, Nishida N, Matsumoto T, Kamatari Y, Hosokawa-Muto J, Kodama K . Hot spots in prion protein for pathogenic conversion. Proc Natl Acad Sci U S A. 2007; 104(29):11921-6. PMC: 1924567. DOI: 10.1073/pnas.0702671104. View

17.

Singh J, Udgaonkar J . Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry. J Mol Biol. 2013; 425(18):3510-21. DOI: 10.1016/j.jmb.2013.06.009. View

18.

Swietnicki W, Morillas M, Chen S, Gambetti P, Surewicz W . Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry. 2000; 39(2):424-31. DOI: 10.1021/bi991967m. View

19.

Tycko R, Savtchenko R, Ostapchenko V, Makarava N, Baskakov I . The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry. 2010; 49(44):9488-97. PMC: 3025268. DOI: 10.1021/bi1013134. View

20.

Honda R, Xu M, Yamaguchi K, Roder H, Kuwata K . A Native-like Intermediate Serves as a Branching Point between the Folding and Aggregation Pathways of the Mouse Prion Protein. Structure. 2015; 23(9):1735-1742. PMC: 4640677. DOI: 10.1016/j.str.2015.07.001. View